Ophthalmologic emergencies in the patient with diabetes

Endocrinology and Metabolism Clinics of North America

Volumn 29, Issue 4, 2000, Pages 813-829

  Wipf, Joyce E ^a,b   Paauw, Douglas S ^a  

^a UNIVERSITY OF WASHINGTON   (United States)

^b VA PUGET SOUND HEALTH CARE SYSTEM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACICLOVIR; ALPHA TOCOPHEROL; GABAPENTIN; OPIATE; TRICYCLIC ANTIDEPRESSANT AGENT;

CENTRAL RETINA ARTERY OCCLUSION; CENTRAL RETINA VEIN OCCLUSION; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIABETES MELLITUS; DIABETIC RETINOPATHY; DOUBLE BLIND PROCEDURE; ENDOPHTHALMITIS; EYE DISEASE; HERPES ZOSTER OPHTHALMICUS; HUMAN; HUMAN CELL; HUMAN TISSUE; LASER COAGULATION; OPHTHALMOPLEGIA; POSTHERPETIC NEURALGIA; PRIORITY JOURNAL; PROTOZOAL INFECTION; RANDOMIZED CONTROLLED TRIAL; REVIEW; VISUAL FIELD DEFECT; VITRECTOMY;

EID: 0034538068     PISSN: 08898529     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0889-8529(05)70166-3     Document Type: Article

References (88)

1. Vascular endothelial growth factor in ocular fluid of patients with diabetic retinopathy and other retinal disorders
2. Position statement - Diabetic retinopathy
3. Endoscopic sinus surgery in the management of mucormycosis
4. Ocular palsies in the absence of other neurological or ocular symptoms: Analysis of 105 cases
5. Treatment of central retinal vein occlusion
6. Postherpetic neuralgia: Role of gabapentin and other treatment modalities
7. Prevention of severe ocular herpes zoster complications by adequate acyclovir therapy
8. Effects of intensified insulin treatment on various lesions of diabetic retinopathy
9. Herpes zoster: Correlation of age, sex, distribution, neuralgia and associated disorders
10. High-dose vitamin E. supplementation normalizes retinal blood flow, creatinine clearance in patients with type 1 diabetes
11. Rhinocerebral mucormycosis: Predisposing factors, diagnosis, therapy, complications, survival
12. Raised plasma homocysteine as a risk factor for retinal vascular occlusive disease
13. Effect of lisinopril on progression of retinopathy in normotensive people with type 1 diabetes
14. Early vitrectomy and endolaser photocoagulation in patients with type 1 diabetes with severe vitreous hemorrhage
15. Endogenous Klebsiella endophthalmitis - A case series
16. Septic melastatic lesions of pyogenic liver abscess: Their association with Klebsiella pneumonia bacteremia in diabetic patients
17. Diabetic retinopathy after combined kidney-pancreas transplantation
18. Oral acyclovir in the treatment of acute herpes zoster ophthalmicus
19. Reduction of the ocular complications of herpes zoster ophthalmicus by oral acyclovir
20. Relative pupillary sparing third nerve palsies: To arteriogram or not?
21. Diseases of the retina
22. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus
23. Diabetes-induced vascular dysfunction in the retina: Role of endothelins
24. Early worsening of diabetic retinopathy in the Diabetes Control and Complications Trial
25. Preliminary report of effects of photocoagulation therapy
26. Early vitrectomy for severe vitreous hemorrhage in diabetic retinopathy: Four-year results of a randomized trial: Diabetic Retinopathy Vitrectomy Study Report 5
27. Long-term visual outcome in proliferative diabetic retinopathy patients after panretinal photocoagulation
28. Multiple retinal arteriolar occlusions associated with coexisting primary antiphospholipid syndrome and factor V. Leiden mutation
29. Causes of severe visual loss in the early treatment diabetic retinopathy study: ETDRS report no. 24
30. Effects of aspirin treatment on diabetic retinopathy: ETDRS report no. 8
31. Fundus photographic risk factors for progression of diabetic retinopathy: ETDRS report no. 12
32. Photocoagulation for diabetic macular edema - ETDRS report no. 1
33. Results of the Endophthalmitis Vitrectomy Study: A randomized trial of immediate vitrectomy and of intravenous antibiotics for the treatment of postoperative bacterial endophthalmitis
34. Endophthalmitis following cataract extraction: A study of 24 cases in 4498 operations
35. Treatment of diabetic retinopathy
36. Cerebral mucormycosis: Ocular findings and review of the literature
37. Varicella-zoster virus is strongly associated with atypical necrotizing herpetic retinopathies
38. Diabetic ophthalmoplegia with special reference to the pupil
39. Retinal vascular occlusion and deficiencies in the protein C. pathway
40. Reviews of hepatic abscess from Klebsiella pneumoniae: An association with diabetes mellitus and septic endophthalmitis
41. Management of Ophthalmic zoster
42. Natural history of herpes zoster ophthalmicus and predictors of postherpetic neuralgia and ocular involvement
43. Oral acyclovir in herpes zoster ophthalmicus
44. Natural therapies for ocular disorders, part one: Diseases of the retina
45. Progression of retinopathy after improved metabolic control in type 2 diabetic patients: Relation of IGF-I and hemostatic variables
46. Herpes zoster
47. Oral acyclovir for herpes zoster ophthalmicus
48. Pupil involvement in patients with diabetes-associated oculomotor nerve palsy
49. The emerging role of magnetic resonance arteriography in the management of patients with third cranial nerve palsy
50. Primary care Infections in patients with diabetes mellitus
51. A case of fatal rhinocerebral mucormycosis with new onset diabetic ketoacidosis
52. Mucormycosis in children: Review of the literature and report of cases
53. The epidemiology of diabetic retinopathy: Findings from the Wisconsin Epidemiologic Study of Diabetic Retinopathy
54. Two-year experience with continuous subcutaneous insulin infusion in relation to retinopathy and neuropathy
55. Enogenous Klebsiella pneumoniae endophthalmitis in diabetic patients
56. Diabetic retinopathy should not be a contraindication to thrombolytic therapy for acute myocardial infarction: Review of ocular hemorrhage incidence and location in the GUSTO-1 trial
57. Herpes zoster ocular infection
58. Topical acyclovir in herpes zoster ocular involvement
59. A comparison of topical acyclovir with steroids in the treatment of herpes zoster keratouveitis
60. Belter glycaemic control and risk reduction of diabetic complications in type 2 diabetics: Comparison with DCCT
61. Acute visual change
62. Diabetic retinopathy
63. Comparison of topical and oral acyclovir in early herpes zoster ophthalmicus
64. Significance of diabetes mellitus in the activation of the varicella zoster virus
65. Endogenous bacterial endophthalmitis: Report of ten-year retrospective study
66. Endophthalmitis after cataract surgery: Long term follow up
67. Postoperative endophthalmitis in association with diabetes mellitus
68. Influence of long-term insulin infusion pump treatment of type 1 diabetes on diabetic retinopathy
69. Herpes zoster and diabetes mellitus: An epidemiological investigation
70. Successful treatment of rhinocerebral mucormycosis by a combination of aggressive surgical debridement and the use of systemic liposomal amphotericin B andlocal therapy with nebulized amphotericin - A case report
71. Paralysis of the third, fourth, and sixth cranial nerves
72. Zygomycosis
73. Fundoscopy: A forgotten art?
74. Gabapentin for the treatment of postherpetic neuralgia: A randomized controlled trial
75. Aggressive systematic treatment for central retinal artery occlusion
76. Rhinocerebral zygomycosis treated with liposomal amphotericin B and surgery
77. Endophthalmitis after secondary lens implantation. A case-report study
78. The systemic evaluation of acute retinal artery occlusion
79. Development of a multifield fundus photographing system using a non-mydriatic camera for diabetic retinopathy
80. Vitrectomy for complications of diabetic retinopathy
81. Vitreous hemorrhage
82. Diagnosis of diabetic eye disease
83. The use of digital cameras in a mobile retinal screening environment
84. Managing oculomotor palsy
85. Bilateral endogenous Escherichia coli endophthalmitis: A devastating complication in an insulin-dependent diabetic
86. The management of acute visual failure
87. Chronic ocular zoster
88. Ophthalmoplegia in diabetes mellitus